These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9052912

  • 1. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes.
    Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, Hirabayashi N, Moriyama Y, Harada M, Asano S, Hara H, Shibata A.
    Bone Marrow Transplant; 1997 Mar; 19(5):461-6. PubMed ID: 9052912
    [Abstract] [Full Text] [Related]

  • 2. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E, Al Mahr M, Chaudhri N, Al Mohareb F, Al Zahrani H, Al Jefri A, Al Omar H, Al Shanqeeti A, Seth P, Aslam M, El Solh H, Aljurf M.
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 4. Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT.
    Godder K, Pati A, Abhyankar S, Gee AP, Parrish R, Lee C, Henslee-Downey PJ.
    Bone Marrow Transplant; 1996 Jan; 17(1):49-53. PubMed ID: 8673054
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 7. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group.
    Arnold R, de Witte T, van Biezen A, Hermans J, Jacobsen N, Runde V, Gratwohl A, Apperley JF.
    Bone Marrow Transplant; 1998 Jun; 21(12):1213-6. PubMed ID: 9674854
    [Abstract] [Full Text] [Related]

  • 10. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S, Yabe H, Kato S, Imoto S, Maruta A, Yoshida T, Gondo H, Morishima Y, Kodera Y.
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [Abstract] [Full Text] [Related]

  • 11. Second bone marrow transplantation for leukemia in untreated relapse.
    Martino R, Badell I, Brunet S, Sureda A, Nomdedéu J, Altés A, Ayats R, Cubells J, Baiget M, Domingo-Albós A.
    Bone Marrow Transplant; 1994 Oct; 14(4):589-93. PubMed ID: 7858533
    [Abstract] [Full Text] [Related]

  • 12. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

  • 13. Second marrow transplants for graft failure in patients with thalassemia.
    Gaziev D, Polchi P, Lucarelli G, Galimberti M, Sodani P, Angelucci E, Giardini C, Baronciani D, Erer B.
    Bone Marrow Transplant; 1999 Dec 01; 24(12):1299-306. PubMed ID: 10627638
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
    Labar B, Masszi T, Morabito F, Mistrik M, Holowiecki J, Bogdanić V, Nemet D, Mrsić M, Krieger O, Lutz D.
    Bone Marrow Transplant; 1996 Jun 01; 17(6):1009-12. PubMed ID: 8807107
    [Abstract] [Full Text] [Related]

  • 15. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
    de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S.
    Bone Marrow Transplant; 2000 Aug 01; 26(3):333-8. PubMed ID: 10967575
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 01; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct 01; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 18. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY, Weisdorf DJ, Davies SM, Enright H, Kersey JH, McGlave PB, Miller W, Ramsay NK, Steinbuch M, Wagner JE, Blazar BR.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):39-42. PubMed ID: 8673052
    [Abstract] [Full Text] [Related]

  • 19. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M.
    Bone Marrow Transplant; 2004 Oct 01; 34(8):721-7. PubMed ID: 15322568
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul 01; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.